The Journal of Experimental Medicine · 1996 · 104 citations · 47 references
Life SciencesImmunologyMolecular BiologyCell SignalingCellular ImmunologySignal TransductionCell Surface Receptor SignalingCytokine BiologyCytokine Receptor SignalingCytokine SignalingImmune SignalingInflammatory SignalingCytokine Gene Expression RegulationCytokine Receptor ExpressionCytokine-induced Gene ExpressionInterleukin-1 Family CytokinesSignal Transduction Pathway ActivationSignal Transduction Pathway Disruption
The hypothesis that the type II receptor (RII) acts as a decoy for interleukin-1 (IL-1) was tested by gene transfer in cells expressing only the type I receptor (8387 fibroblasts). RII-transfected cells showed defective responsiveness to IL-1 in terms of NFkappaB activation, cytokine gene expression and production. Blocking monoclonal antibodies against RII restored the capacity of RII-transfected cells to respond to IL-1 beta. Hence defective IL-1 responsiveness of RII-transfected cells requires surface expression of the molecule. RII-transfected cells showed normal responsiveness to TNF, which shares functional properties and elements in the signal transduction pathway with IL-1. Cells transfected with a deletion mutant of RII missing 26 of 29 amino acids of the cytoplasmic portion of the molecule showed impaired responsiveness to IL-2. Cells transfected with full-length or the cytoplasmic deletion mutant of RII released copious amounts of RII in the supernatant. However, transfected cells showed defective responsiveness to brief exposure to IL-1, in the absence of measurable released RII. These results indicate that impairment of the responsiveness to IL-1 following RII gene transfer was dependent upon surface expression of the molecule, specific for IL-1 and unaffected by truncation of the cytoplasmic portion. Thus, the type II "receptor" is a decoy surface molecule, regulated by antiinflammatory signals, whose only known function is to capture and block IL-1.
47
Interleukin-1 and interleukin-1 antagonism
CA Dinarello · Blood · 1991 · 2.3K citations · Full text
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Charles Hannum, Carol Wilcox, William P. Arend et al. · Nature · 1990 · 1.1K citations
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Francesco Colotta, Fabio Re, Marta Muzio et al. · Science · 1993 · 982 citations
Life Sciences, Immunology, Pathology +15